T32 Trainees
Current Trainees
Pre-doctoral
Stefan Lundh
Advised by Ben Stanger
Project: The role of TOX in CD4 T cells during chronic LCMV infection
Post-doctoral Trainees
Daniel Hwang, PhD
Advised by John Maris, MD
Project: Leveraging HLA-I chaperones to enhance antigen presentation in cancers
Jessie Axsom, RN, PhD
Advised by Will Bailis, PhD, & Saar Gill, MD, PhD
Project: Mechanisms linking macrophage lipid handling and inflammation in metabolic-associated liver diseases and hepatocellular carcinoma
Molly Bunkofske, PhD
Advised by Chris Hunter, PhD
Project: CD8+ T cell recognition of Toxoplasma gondii cysts during chronic CNS infection
Sean Callahan, PhD
Advised by Shelley Berger, PhD
Project: Metabolic-Epigenetic Axis in Microglia Development and Activity
Austin Good, PhD
Advised by Ben Stanger, MD, PhD
Project: Mechanisms of PARPi resistance in hrdPDAC
Emily Goering, PhD
Advised by Warren Pear, MD, PhD & Malay Haldar, MD, PhD
Project: Neutrophil modulation of the tumor immune response
Cordelia McGehee, MD, PhD
Advised by Sydney Shaffer, MD, PhD
Project: A quantitative approach for immune cell mediated killing and tumor escape
Donn Van Deren, PhD
Advised by Malay Haldar, MD, PhD
Project: Exploring the impact of non-CNS tumors on brain immune function
Recent Past Trainees
Isabel Breuer
Advised by Kristen Lynch, PhD
Project: T cell signaling and cancer
Currently: Isabel is continuing her Phd studies in Kristen Lynch's lab.
Shannon McGettigan, PhD
Advised by David Allman, PhD
Project: Investigating survival mechanisms in normal and malignant plasma cells.
Awards: CRI Postdoctoral Fellowship
Currently: Shannon continues her post-doctoral studies under the guidance of Dr. Dave Allman.
Rumeysa, Biyik-Sit, PhD
Advised by Kai Tan, PhD
Project: The role of tumor-associated macrophage (TAM)-derived HB-EGF in high-risk neuroblastoma chemoresistance
Currently: Rumeysa continues her post-doctoral studies under the guidance of Dr. Kai Tan.
Grant Kinsler, PhD
Advised by Arjun Raj, PhD
Project: Probing the functional effects of oncogenes at the single cell level
Currently: Grant continues his post-doctoral studies under the guidance of Dr. Arjun Raj.
Charles Drummer IV, PhD
Advised by Andrei Thomas-Tikhonenko, PhD
Project: Neuroblastoma-specific isoforms of receptor protein tyrosine phosphatases as immunotherapy targets
Currently: Charles continues his post-doctoral studies under the guidance of Dr. Andrei Thomas-Tikhonenko.
Ben Kahn, PhD
Advised by Ben Stanger, MD, PhD
Project: The lymph node is an intrinsically tolerant site for metastasis
Currently: Ben completed his PhD and continues his post-doctoral studies under the guidance of Dr. Ben Stanger.
Samantha Kemp, PhD
Advised by Ben Stanger, MD, PhD
Project: Using a cancer-on-a-chip approach to study the pancreatic cancer tumor microenvironment
Current Position: Scientist, Frederick National Laboratory for Cancer Research
Tatiana Blanchard, PhD
Advised by Beatriz Carreno, PhD & Carl June, MD
Project: Translocation induced LOXHD1 is an immunological target for Ewing Sarcoma
Current Position: Co-Founder & CEO Laurel Biotherapeutics
Andrew Rech, M.D., PhD
Advised by Carl June
Project: Overcoming barriers for successful CAR T cell therapy in solid tumors.
Current Position: Instructor, Pathology and Laboratory Medicine, University Of Pennsylvania
Amber Hamilton, PhD
Advised by John Maris, MD
Project: Multiomics to discover and validate immunotherapies in pediatric cancers
Kelly Rome, PhD
Advised by Will Bailis, PhD
Project: Elucidating the role of Branched-Chain Amino Acid metabolism in T cell immunity
Laura Kim, PhD
Advised by Celeste Simon, PhD
Project: Competition for Arginine between HCC tumor and immune cells
Awards: American Cancer Society Postdoctoral Fellowship
Nicholas Lesner, PhD
Advised by Celeste Simon, PhD
Project: Hepatic Urea Cycle Function in Hepatocellular Carcinoma
Awards: Damon Runyon Postdoctoral Fellowship (Accepted)
Khoa Tran, PhD
Advised by Shelley Berger, PhD
Project: Investigation of chromatin dynamics underlying cellular senescence.
Current Position: Assistant Professor, Tufts University
Divij Matthew, PhD
Advised by E. John Wherry, PhD
Project: Pembrolizumab with delayed Itacitinib pulse for first line treatment of metastatic lung cancer
Current Position: Research Associate of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania.
Gregory Schwartz, MD, PhD
Advised by R. Babak Faryabi, PhD, & Warren Pear, MD, PhD
Project: Deconvoluting the hierarchy of single cell communities
Current Position: Scientist at the Princess Margaret Cancer Centre & Assistant Professor in the Department of Medical Biophysics at the University of Toronto.
Neil Sullivan, PhD
Advised by Steven Albelda, MD
Project: Characterization of tumor NK cell subsets from early-stage NSCLC patients
Current Position: R&D Senior Scientist: Immuno-Oncology
Joseph Pereira (Perry), PhD
Advised by Christopher Hunter, PhD
Project: PD-L1 –PD-1 interactions limit effector Treg cell populations at homeostasis and during infection
Current Position: Post-doc, Sharpe Lab, Harvard University
Philip Rommel, PhD
Advised by Carl June, MD
Project: Enhancing tumor infiltration of CAR T cells through the expression of RUNX3
Current Position: Research Associate, Pathology & Laboratory Medicine, University of Pennsylvania
Derek Oldridge, M.D., PhD
Advised by E. John Wherry, PhD
Project: Spatial profiling of the solid tumor immune microenvironment at single cell resolution
Current Position: Assistant Professor of Pathology and Laboratory Medicine, University of Pennsylvania